Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, COVID-19 virus infection, Date of authorisation: 28/01/2022, Revision: 11, Status: Authorised
TO: